GNTX.NASDAQGentex CORP

Form 4: Director Billy Pink Receives Gentex Stock Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Gentex Corporation director Billy Pink was granted 5,626 shares of common stock as part of an equity compensation award.

Summary

  • Director Billy Pink acquired 5,626 shares of Gentex Corporation (GNTX) common stock on May 21, 2026.
  • The shares were granted at a price of $0.00, representing an equity award.
  • Following this transaction, Billy Pink's total direct beneficial ownership in the company is 15,329 shares.
  • The granted shares are subject to a 100% vesting schedule one year from the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

  • Alignment of director interests with shareholders through equity-based compensation.
  • Increase in total beneficial ownership by a member of the board.

Negatives

  • None identified in this filing.

Risks

  • The shares are subject to a one-year vesting period, meaning the director does not have immediate liquidity or full ownership rights until the vesting date.

Future Outlook

The shares granted will vest 100% one year from the grant date of May 21, 2026.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term performance and align board members with shareholder interests in the automotive technology sector.

Comparison to Industry Standards

  • The use of time-based vesting for director equity is consistent with standard practices for S&P 400 and automotive component manufacturers.
  • The grant size is typical for non-executive director compensation packages in mid-cap industrial companies.

Stakeholder Impact

  • Shareholders: Positive signal as it aligns director incentives with company performance.

Next Steps

  • Vesting of the 5,626 shares on May 21, 2027.

Key Dates

DateDescription
05/16/2024Date of Power of Attorney execution.
05/21/2026Date of the equity grant transaction.
05/22/2026Date of filing the Form 4 with the SEC.

Keywords

Gentex, GNTX, Director, Equity Grant, Insider Transaction, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.